Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,710 | 346 | 99.8% |
| Education | $13.34 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,049 | 80 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $973.17 | 56 | $0 (2023) |
| Lilly USA, LLC | $496.97 | 33 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $389.52 | 26 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $356.82 | 21 | $0 (2023) |
| GlaxoSmithKline, LLC. | $315.48 | 18 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $308.09 | 16 | $0 (2022) |
| Amarin Pharma Inc. | $173.13 | 10 | $0 (2022) |
| ABBVIE INC. | $143.75 | 9 | $0 (2022) |
| Astellas Pharma US Inc | $142.44 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $362.34 | 20 | AstraZeneca Pharmaceuticals LP ($90.51) |
| 2022 | $676.82 | 37 | AstraZeneca Pharmaceuticals LP ($117.39) |
| 2021 | $1,115 | 57 | Novo Nordisk Inc ($137.94) |
| 2020 | $1,211 | 73 | AstraZeneca Pharmaceuticals LP ($289.32) |
| 2019 | $1,117 | 81 | Novo Nordisk Inc ($277.90) |
| 2018 | $764.38 | 51 | Novo Nordisk Inc ($207.84) |
| 2017 | $476.49 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($139.81) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 05/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 04/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardio-renal | ||||||
| 04/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 04/01/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: INSOMNIA | ||||||
| 02/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardio-renal | ||||||
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Urology | ||||||
| 02/13/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 01/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: RESPIRATORY | ||||||
| 01/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes | ||||||
| 01/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: VACCINES | ||||||
| 11/17/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 11/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 11/07/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Diabetes | ||||||
| 10/28/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,229 | 1,366 | $56,535 | $25,654 |
| 2022 | 22 | 2,101 | 2,961 | $139,875 | $64,738 |
| 2021 | 28 | 2,308 | 3,371 | $146,335 | $71,375 |
| 2020 | 30 | 2,582 | 3,821 | $174,275 | $75,361 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 156 | $30,420 | $11,161 | 36.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 100 | 108 | $3,240 | $1,778 | 54.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 53 | 56 | $2,520 | $1,625 | 64.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 103 | 112 | $2,800 | $1,469 | 52.5% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2023 | 64 | 70 | $2,100 | $1,239 | 59.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 106 | 119 | $2,380 | $1,232 | 51.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 123 | 145 | $1,450 | $1,218 | 84.0% |
| 83721 | Ldl cholesterol level | Office | 2023 | 103 | 112 | $2,240 | $1,152 | 51.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $2,800 | $997.11 | 35.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 64 | 65 | $1,625 | $960.70 | 59.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 97 | 106 | $1,590 | $937.04 | 58.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 99 | 111 | $1,665 | $844.71 | 50.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 69 | 75 | $375.00 | $295.50 | 78.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 45 | 50 | $500.00 | $283.00 | 56.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 45 | 50 | $500.00 | $254.00 | 50.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $330.00 | $208.12 | 63.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 346 | $67,470 | $27,102 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 104 | $14,560 | $6,477 | 44.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 162 | 231 | $6,930 | $3,839 | 55.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 167 | 239 | $5,975 | $3,165 | 53.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 83 | 95 | $4,275 | $2,789 | 65.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 171 | 261 | $5,220 | $2,726 | 52.2% |
| 83721 | Ldl cholesterol level | Office | 2022 | 167 | 239 | $4,780 | $2,482 | 51.9% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2022 | 99 | 131 | $3,930 | $2,342 | 59.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $5,950 | $2,325 | 39.1% |
About Dr. Gloria Hernandez, MD
Dr. Gloria Hernandez, MD is a Internal Medicine healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1922235506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gloria Hernandez, MD has received a total of $5,723 in payments from pharmaceutical and medical device companies, with $362.34 received in 2023. These payments were reported across 348 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,710).
As a Medicare-enrolled provider, Hernandez has provided services to 8,220 Medicare beneficiaries, totaling 11,519 services with total Medicare billing of $237,127. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Summerfield, FL
- Active Since 06/22/2009
- Last Updated 01/11/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922235506
Products in Payments
- FARXIGA (Drug) $695.60
- Ozempic (Drug) $645.27
- INVOKANA (Drug) $348.26
- JARDIANCE (Drug) $281.16
- BYDUREON (Drug) $183.45
- Vascepa (Drug) $173.13
- TRULICITY (Drug) $166.20
- Tresiba (Drug) $161.07
- TRELEGY ELLIPTA (Drug) $156.52
- VRAYLAR (Drug) $140.17
- XIFAXAN (Drug) $134.05
- Kerendia (Drug) $128.48
- Rybelsus (Drug) $126.75
- DEXCOM G6 TRANSMITTER (Device) $118.05
- SHINGRIX (Biological) $106.74
- SOLIQUA 100/33 (Drug) $104.44
- MYRBETRIQ (Drug) $102.29
- STIOLTO RESPIMAT (Drug) $97.09
- ENTRESTO (Drug) $96.48
- SOLIQUA 100/33 (Biological) $81.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Summerfield
Dr. Marivic Villa, M.d, M.D
Internal Medicine — Payments: $6,986
Luna Beck, M.d, M.D
Internal Medicine — Payments: $2,672
Dr. Ma Aung, M.d, M.D
Internal Medicine — Payments: $2,316
Mrs. Sara Gitte, Md, MD
Internal Medicine — Payments: $2,272
Dr. Page Smith, M.d, M.D
Internal Medicine — Payments: $2,256
Dr. Thomas Mathew, M.d, M.D
Internal Medicine — Payments: $2,075